LandGate Releases Comprehensive Data on Solar Development in Massachusetts
BOSTON, May 21, 2024 /PRNewswire/ — LandGate, a leading provider of data solutions for renewable energy site analysis, is pleased to announce the release of... Read more.
ZIM Reports Financial Results for the First Quarter of 2024; Raising Full Year 2024 Guidance
Reported Revenues of $1.56 Billion, Net Income of $92 Million, Adjusted EBITDA1 of $427 Million and Adjusted EBIT of $167 Million Increased Full Year 2024 Guidance... Read more.
Tech Companies Announce A New Coalition To Fight Online Fraud & Pig Butchering Scams
Tech Against Scams includes leading tech firms, Match Group, Coinbase, Meta, and Ripple who will work together to help prevent and disrupt financial scams throughout... Read more.
AKTIS ONCOLOGY ENTERS INTO STRATEGIC COLLABORATION WITH LILLY TO DISCOVER AND DEVELOP NOVEL ANTICANCER RADIOPHARMACEUTICALS
Collaboration to utilize Aktis Oncology’s proprietary miniprotein discovery platform to generate novel tumor-targeting radiopharmaceuticals Aktis responsible... Read more.
Event Security During the Summer in California: The Do’s and Don’ts for the Hottest Events in History
Fast Guard Service shares the do’s and don’t from an event planners point of view LOS ANGELES, May 21, 2024 /PRNewswire/ — Introduction Hello,... Read more.
Transposon Receives US FDA Fast Track Designation for TPN-101 for Progressive Supranuclear Palsy
Designation Supports Accelerated Drug Development for PSP TPN-101 is the First PSP Treatment to Reduce NfL and IL-6 Levels, Key Biomarkers of Neurodegeneration and... Read more.
Aily Labs Unveils Aily Agent: The Latest Innovation in the AI-Powered Decision Intelligence App for Enterprises
The Aily Agent is an add-on feature in the Aily Labs mobile app that uses agentive AI to provide forward-thinking, personalized recommendations for corporate decision-making,... Read more.
Dragonfly Therapeutics, Inc. Announces Clinical Collaboration to Evaluate DF9001, an EGFR targeting TriNKET®, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors
DF9001 is currently being evaluated as a monotherapy for the treatment of Non-Small Cell Lung Cancer, Renal Cell Carcinoma and Head and Neck Squamous Cell Carcinoma.... Read more.
Vlasic Pickles Teams Up with Think Royln for Fashion-Forward Pickleball Collaboration
Limited-Edition Pickleball Clothing and Accessories Available While Supplies Last CHICAGO, May 21, 2024 /PRNewswire/ — Vlasic® Pickles, a brand of Conagra... Read more.
Benchling Welcomes Chief Financial Officer Ron Gill and Chief Revenue Officer Parm Uppal
R&D Cloud leader crosses $200M in annualized revenue and continues product momentum SAN FRANCISCO, May 21, 2024 /PRNewswire/ — Benchling, the R&D... Read more.